Rick E. Winningham, Chief Executive Officer at THERAVANCE INC (THRX), sold 252,300 shares at $23.49 ($5.6M) on 2011-02-28, disclosed to the SEC on 2011-02-28.
Scheduled sale ($5.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.45 | 93,100 | $2.0M | 35.6% |
| 2 | $22.22 | 50,200 | $1.1M | 19.9% |
| 3 | $22.74 | 42,000 | $955K | 17.0% |
| 4 | $22.49 | 29,800 | $670K | 11.9% |
| 5 | $23.49 | 37,200 | $874K | 15.6% |
| Total | $22.24 avg | 252,300 |
| $5.6M |
| 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| TBPH | SELL | 2022-12-16 | $560K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |